Evidence map›Paper›PMID 39140049›Full record

ArticleACS medicinal chemistry letters2024

Chemical Probes to Investigate Central Nervous System Disorders: Design, Synthesis and Mechanism of Action of a Potent Human Serine Racemase Inhibitor.

Francesco Marchesani, Francesca Rebecchi, Marco Pieroni, Serena Faggiano, Giannamaria Annunziato, Chiara Spaggiari, Stefano Bruno, Sofia Rinaldi, Roberta Giaccari, Gabriele Costantino and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS medicinal chemistry letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francesco MarchesaniDepartment of Medicine and Surgery, University of Parma, 43126 Parma, Italy.
Francesca RebecchiDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Marco PieroniDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.ORCID https://orcid.org/0000-0001-9190-3712
Serena FaggianoDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Giannamaria AnnunziatoDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.ORCID https://orcid.org/0000-0001-9629-6966
Chiara SpaggiariDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Stefano BrunoDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Sofia RinaldiDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Roberta GiaccariDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Gabriele CostantinoDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.
Barbara CampaniniDepartment of Food and Drug, University of Parma, 43124 Parma, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intricate signaling network within the central nervous system (CNS) involving

Identifiers

PMID39140049
PMCPMC11318019

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.